SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012420
Filing Date
2018-05-09
Accepted
2018-05-09 16:16:34
Documents
70
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20180331.htm 10-Q 1706790
2 EX-10.1 dvax-ex101_596.htm EX-10.1 24504
3 EX-10.2 dvax-ex102_691.htm EX-10.2 171050
4 EX-10.3 dvax-ex103_466.htm EX-10.3 1429742
5 EX-31.1 dvax-ex311_7.htm EX-31.1 17705
6 EX-31.2 dvax-ex312_10.htm EX-31.2 17649
7 EX-32.1 dvax-ex321_8.htm EX-32.1 5945
8 EX-32.2 dvax-ex322_9.htm EX-32.2 6197
  Complete submission text file 0001564590-18-012420.txt   8122596

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT dvax-20180331.xml EX-101.INS 1424280
10 XBRL TAXONOMY EXTENSION SCHEMA dvax-20180331.xsd EX-101.SCH 49929
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20180331_cal.xml EX-101.CAL 51154
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20180331_def.xml EX-101.DEF 168363
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20180331_lab.xml EX-101.LAB 388450
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20180331_pre.xml EX-101.PRE 300425
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 18818477
SIC: 2834 Pharmaceutical Preparations